Health IT Security June 29, 2022
Researchers found that though many digital health companies have low levels of clinical robustness, about 20 percent had high scores in this arena.
Despite the rapid growth of the digital health sector in recent years, a study published in the Journal of Medical Internet Research found that many digital health companies have low levels of clinical robustness, indicating a need for further clinical validation.
The digital health sector has seen rapid growth over the past decade, particularly during the COVID-19 pandemic. In the first quarter of 2022, digital health funding totaled $6 billion, with an average deal size of $32.8 million, according to data from Rock Health. This figure is extremely high, though it trails the $7.3 billion raised...